Human tPA FlowCytomix Simplex

Description: This FlowCytomix Simplex Kit is designed for the measurement of Human t-PA in an immunoassay analyzed on a flow cytometer. Together with the FlowCytomix Human Basic Kit (cat. BMS8420FF), this kit can be used to detect t-PA alone or can be multiplexed with other Simplex Kits to measure a variety of analytes.

This kit contains bead population A5.

Tissue-type plasminogen activator (t-PA) is a serine protease which occurs in blood plasma, serum, other body fluids, tissues and conditioned media of certain cultured cells. It can convert the inactive proenzyme plasminogen to the active protease plasmin. Plasmin can degrade fibrin, the matrix of a blood clot in a process known as fibrinolysis, leading to dissolution of the clot. Furthermore plasminogen activation is implicated in metastatic spread of malignant cells and in tissue remodelling.
Fibrin has been shown to accelerate the conversion of plasminogen to plasmin which is mediated by t-PA. Through this pathway fibrin promotes its own degradation. Inhibitors to t-PA have been found in blood preparations, cell culture media and tissues. These plasminogen activator inhibitors -1 and -2 (PAI-1, PAI-2) react extremely rapidly with t-PA, forming inactive complexes. The availability of free active t-PA is regulated through this interaction.

Citations: Wang,J.; Zhang,S.; Jin,Y.; Qin,G.; Yu,L.; Zhang,J.. Elevated levels of platelet-monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome. Int J Cardiol. 2007;115:361-365. (Link)

Aradi,Daniel; Konyi,Attila; Palinkas,Laszlo; Berki,Timea; Pinter,Tunde; Tahin,Tamas; Horvath,Ivan; Papp,Lajos; Komocsi,Andras. Thienopyridine Therapy Influences Late Outcome After Coronary Stent Implantation. Angiology 2008;59:172-178. (Link)

Bakouboula,Babe; Morel,Olivier; Faure,Antoine; Zobairi,Fatiha; Jesel,Laurence; Trinh,Annie; Zupan,Michel; Canuet,Matthieu; Grunebaum,Lelia; Brunette,Agnes; Desprez,Dominique; Chabot,Francois; Weitzenblum,Emmanuel; Freyssinet,Jean Marie; Chaouat,Ari; Toti,Florence. Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine 2008;177:536-543. (Link)

References: Mehta,J.; Mehta,P.; Lawson,D.; Saldeen,T.. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. J.Am.Coll.Cardiol. 1987;9:263-268. (Link)

Okabe,K.; Kato,I.; Sato,S.; Kashiwabara,T.; Furuta,S.; Sato,H.; Tanikawa,K.; Kumashiro,R.; Kanayama,M.. Clinical evaluation of tissue plasminogen activator (t-PA) levels in patients with liver diseases. Gastroenterol.Jpn. 1992;27:61-68. (Link)

Li,Y.; Chen,H.; Tan,J.; Wang,X.; Liang,H.; Sun,X.. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity. Eur.J.Clin.Invest 1998;28:1050-1054. (Link)

Olofsson,B.O.; Dahlen,G.; Nilsson,T.K.. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur.Heart J. 1989;10:77-82. (Link)

Hara,M.; Ito,K.; Nawata,T.; Tsunematsu,Y.; Shimoyama,N.; Maeda,T.; Sato,Y.; Saikawa,T.; Sakata,T.. Plasma plasminogen activator inhibitor-1, tissue plasminogen activator and serum lipoprotein(a) after reperfusion therapy in acute myocardial infarction: comparison between sequential and direct percutaneous transluminal coronary angioplasty. Cardiology 1995;86:407-410. (Link)

Skrha,J.; Hodinar,A.; Kvasnicka,J.; Stibor,V.; Sperl,M.; Stolba,P.; Hilgertova,J.. Early changes of serum N-acetyl-beta-glucosaminidase, tissue plasminogen activator and erythrocyte superoxide dismutase in relation to retinopathy in type 1 diabetes mellitus. Clin.Chim.Acta 1994;229:5-14. (Link)

Smith,F.B.; Lee,A.J.; Rumley,A.; Fowkes,F.G.; Lowe,G.D.. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease. Atherosclerosis 1995;115:35-43. (Link)

Warshofsky,M.K.; Wasserman,H.S.; Wang,W.; Teng,P.; Sciacca,R.; Apfelbaum,M.; Schwartz,A.; Michler,R.E.; Mancini,D.M.; Cannon,P.J.; Rabbani,L.E.. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients. Am.J.Cardiol. 1997;80:145-149. (Link)

Hamsten,A.; Wiman,B.; de,Faire U.; Blomback,M.. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N.Engl.J.Med. 1985;313:1557-1563. (Link)